Major Depressive Disorder Treatments - Search News

US FDA approves new nasal spray for depression treatment

Hosted on MSN · 1d

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

FDA approves Spravato as monotherapy for adults with major depressive disorder

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as monotherapy for adults with treatment-resistant depression, Johnson & Johnson announced in a press release.

UPI News on MSN · 1d

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

1don MSN

Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

Largest Study to Date Identifies Hundreds of Genes for Major Depression

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

3h

Can Taking Antidepressants Cause Weight Loss?

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results